Back to results
US 12,594,241 B2Granted
Topiramate oral liquid suspension and use thereof
OwnerPaul Sudhakar, Scott Boyerinventors
Life of this patent
Estimating the term…
Abstract
Provided herein is an oral liquid suspension that includes topiramate, as well as methods of medical treatment that include orally administering the oral liquid suspension.
Claims29
An oral liquid suspension comprising:
- 2,3:4,5-Di-O-isopropylidene-β-D-fructopyranose sulfamate (topiramate);
- water;
- glycerin;
- propylene glycol;
- polyethylene glycol;
- methylparaben;
- sodium benzoate;
- xanthan gum;
- carboxymethyl cellulose;
- sodium phosphate;
- and
- microcrystalline cellulose and colloidal silicon dioxide, wherein the topiramate is present in 25+/−5 mg/mL.
9 more elements
An oral liquid suspension comprising:
- 2,3:4,5-Di-O-isopropylidene-β-D-fructopyranose sulfamate (topiramate);
- water;
- glycerin;
- propylene glycol;
- polyethylene glycol;
- methylparaben;
- sodium benzoate;
- xanthan gum;
- carboxymethyl cellulose;
- sodium phosphate;
- and
- microcrystalline cellulose and colloidal silicon dioxide,
- wherein the oral liquid suspension has a viscosity at 25° C. of 300-400 millipoises.
10 more elements
Dependencies are inferred from the claim text.